← Open Payments lookup

J REIMHERR: Open Payments

NPI 1437178993 · LYNN, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,911 in 185 payments from 17 companies in 2025. Trend: 2023 $7,519 · 2024 $3,045 · 2025 $3,911

Food & beverage: $3,896Education: $14
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)30$665
ABBVIE INC.30$531
Neurocrine BioSciences, Inc.15$393
Lundbeck LLC12$364
Teva Pharmaceuticals USA, Inc.14$355
Janssen Pharmaceuticals, Inc10$330
Alkermes, Inc.12$250
E.R. Squibb & Sons, L.L.C.13$241
Axsome Therapeutics, Inc.16$239
Vanda Pharmaceuticals Inc.17$218

Products named: CAPLYTA, VRAYLAR, REXULTI, INGREZZA, INVEGA SUSTENNA, ARISTADA, COBENFY, Auvelity.

Industry payments across MA — which companies pay providers there.